Dialectical Behavior Therapy Reduces Suicidal Behavior in Adults With Autism
By Lori Solomon HealthDay Reporter
MONDAY, April 22, 2024 -- Dialectical behavior therapy (DBT) is safe and shows short-term efficacy in reducing suicidal ideation and suicide attempts in adults with suicidal behavior and autism spectrum disorder (ASD), according to a study published online April 12 in Psychological Medicine.
Anne Huntjens, from Vrije Universiteit in Amsterdam, and colleagues evaluated the effectiveness of DBT versus treatment as usual (TAU) in reducing suicidal ideation and suicide attempts among people with ASD. The analysis included 123 outpatients (18 to 65 years of age) with diagnosed ASD and suicidal behavior who were randomly assigned to DBT or TAU.
The researchers found that at the end of treatment, DBT significantly reduced both suicidal ideation and attempts versus TAU. However, at 12-month follow-up, the differences were no longer statistically significant. Both posttreatment and at 12 months, depression severity significantly decreased with DBT. No differences between the groups were seen for social anxiety. Two suicides occurred in the TAU group.
"This study demonstrated that a shortened 26-week DBT treatment was effective in autistic adults with suicidal ideation and suicide attempts," the authors write. "Specifically, participants received DBT well, as evidenced by the low attrition rate, and DBT was shown to be safe in clinical practice, as it did not provoke severe adverse events."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
U-Shaped Link Detected Between Adolescent BMI and Mental Health
FRIDAY, May 17, 2024 -- There is a U-shaped association between adolescent body mass index (BMI) and mental health, according to a study published online May 15 in JAMA...
GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant Prescription
WEDNESDAY, May 15, 2024 -- Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a...
Child Maltreatment Linked to Externalizing, Internalizing Behavior
TUESDAY, May 14, 2024 -- Child maltreatment is associated with increases in externalizing and internalizing behaviors, according to a study published online May 14 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.